Shuttle Pharmaceuticals Enters Material Definitive Agreement
Ticker: SHPH · Form: 8-K · Filed: Mar 25, 2025 · CIK: 1757499
| Field | Detail |
|---|---|
| Company | Shuttle Pharmaceuticals Holdings, Inc. (SHPH) |
| Form Type | 8-K |
| Filed Date | Mar 25, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, filing
TL;DR
Shuttle Pharma signed a big deal, filing shows.
AI Summary
Shuttle Pharmaceuticals Holdings, Inc. entered into a material definitive agreement on March 21, 2025. The filing also includes financial statements and exhibits related to this agreement. The company is incorporated in Delaware and its principal executive offices are located in Gaithersburg, MD.
Why It Matters
This filing indicates a significant new agreement for Shuttle Pharmaceuticals, which could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — Entering into material definitive agreements can carry inherent risks related to the terms, execution, and potential impact on the company's financial health.
Key Players & Entities
- Shuttle Pharmaceuticals Holdings, Inc. (company) — Registrant
- March 21, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Gaithersburg, MD (location) — Address of principal executive offices
FAQ
What is the nature of the material definitive agreement entered into by Shuttle Pharmaceuticals?
The filing does not specify the exact nature of the material definitive agreement, only that one was entered into on March 21, 2025.
What are the key financial details or terms of this new agreement?
The provided text of the 8-K filing does not contain specific financial details or terms of the material definitive agreement.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on March 21, 2025.
Where are Shuttle Pharmaceuticals Holdings, Inc.'s principal executive offices located?
Shuttle Pharmaceuticals Holdings, Inc.'s principal executive offices are located at 401 Professional Drive, Suite 260, Gaithersburg, MD 20879.
What is the Standard Industrial Classification (SIC) code for Shuttle Pharmaceuticals Holdings, Inc.?
The Standard Industrial Classification (SIC) code for Shuttle Pharmaceuticals Holdings, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 25, 2025 regarding Shuttle Pharmaceuticals Holdings, Inc. (SHPH).